Your table is always ready thanks to Pittsburgh's booming NoWait
Pittsburgh's NoWait offers apps that take the waiting out of casual dining.
10 little things that will pack a big Pittsburgh punch in 2015
From its tiniest residents to its biggest ideas, Pittsburgh made some strategic moves in 2014 that have the potential to reap huge rewards in 2015 and beyond. Keystone Edge details the people, projects and places to watch.
Founder Profile: Michael Gausling of Originate Ventures
After exiting a wildly successful company, this Lehigh Valley entrepreneur co-founded a venture fund, investing in and mentoring promising startups.
Philly's Wash Cycle Laundry cleans up at national demo day
Philadelphia-based Wash Cycle Laundry was the grand-prize winner last week at the first Blackstone LaunchPad Demo Day in New York.
Executive Director of Ben Franklin Venture Investment Forum/Innovation Transfer Network
Are you a Small Manufacturer with a BIG IDEA? Ben Franklin's innovation competition, managed by Edwards, will this year award a prize package valued at $200,000. She chatted with Keystone Edge about how the competition has evolved over the years and
Investment booms in Pittsburgh thanks to new venture fund
Riverfront Ventures will invest $24 million in local early stage companies, enabling Innovation Works to remain connected to its standout incubator graduates.
Ed tech company Frontline grows with new products, financing and a bigger HQ
At the forefront of web-based tools for K-12 education, fast-growing Frontline Technologies is moving to Malvern, nearly doubling its space.
New robotic arms from Pittsburgh's RE2 reach for a range of markets
The reach of Pittsburgh�s RE2 continues to grow, both in terms of its business and its robotic manipulator arms.
Meet the brains behind Pittsburgh's brightest tech ideas
Discover a whirlwind of mind-blowing possibility during the Pittsburgh Regional Alliance's Tech Crawl.
$35 million in capital is a breath of fresh air for Yardley's OptiNose
Yardley's OptiNose has received $35 million in new capital to continue development of its treatment for serious chronic nasal inflammatory diseases (CNID).